VERICEL CORPORATION Net Cash Provided by (Used in) Operating Activities, Continuing Operations
VERICEL CORPORATION (VCEL) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$3.12 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-10
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$3.12M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$9.31M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$4.18M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$5.13M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$19.89M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$13.35M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$25.41M.
- VERICEL CORPORATION net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$19.94M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 270 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 273 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 276 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 279 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 282 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 285 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 288 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 291 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 294 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 297 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$3.12M 10-Q · filed 2017-05-10 | -$12.43M derived: sum of 2 quarters · filed 2017-05-10 | -$16.61M derived: sum of 3 quarters · filed 2017-05-10 | -$21.75M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2016-12-31 | -$9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$13.49M derived: sum of 2 quarters · filed 2017-03-13 | -$18.62M derived: sum of 3 quarters · filed 2017-03-13 | -$19.89M 10-K · filed 2017-03-13 | |||||||||||
| 2016-09-30 | -$4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$9.31M derived: sum of 2 quarters · filed 2016-11-07 | -$10.58M 10-Q · filed 2016-11-07 | -$14.62M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2016-06-30 | -$5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$6.40M 10-Q · filed 2016-08-08 | -$10.44M derived: sum of 3 quarters · filed 2017-05-10 | -$11.16M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2016-03-31 | -$1.27M 10-Q · filed 2017-05-10 | -$5.31M derived: sum of 2 quarters · filed 2017-05-10 | -$6.02M derived: sum of 3 quarters · filed 2017-05-10 | -$10.50M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2015-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$4.75M derived: sum of 2 quarters · filed 2017-03-13 | -$9.23M derived: sum of 3 quarters · filed 2017-03-13 | -$13.35M 10-K · filed 2017-03-13 | |||||||||||
| 2015-09-30 | -$718.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$5.20M derived: sum of 2 quarters · filed 2016-11-07 | -$9.31M 10-Q · filed 2016-11-07 | -$15.55M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2015-06-30 | -$4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$8.59M 10-Q · filed 2016-08-08 | -$14.84M derived: sum of 3 quarters · filed 2017-03-13 | -$23.26M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2015-03-31 | -$4.11M 10-Q · filed 2016-05-10 | -$10.36M derived: sum of 2 quarters · filed 2017-03-13 | -$18.78M derived: sum of 3 quarters · filed 2017-03-13 | -$24.85M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2014-12-31 | -$6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$14.67M derived: sum of 2 quarters · filed 2017-03-13 | -$20.74M derived: sum of 3 quarters · filed 2017-03-13 | -$25.41M 10-K · filed 2017-03-13 | |||||||||||
| 2014-09-30 | -$8.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$14.49M derived: sum of 2 quarters · filed 2015-11-13 | -$19.17M 10-Q · filed 2015-11-13 | -$23.51M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-06-30 | -$6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$10.74M 10-Q · filed 2015-08-12 | -$15.09M derived: sum of 3 quarters · filed 2016-03-14 | -$19.23M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-03-31 | -$4.67M 10-Q · filed 2015-05-14 | -$9.02M derived: sum of 2 quarters · filed 2016-03-14 | -$13.16M derived: sum of 3 quarters · filed 2016-03-14 | -$17.86M derived: sum of 4 quarters · filed 2016-03-14 | -$281.23M 10-Q · filed 2014-05-15 | ||||||||||
| 2013-12-31 | -$4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$8.48M derived: sum of 2 quarters · filed 2016-03-14 | -$13.18M derived: sum of 3 quarters · filed 2016-03-14 | -$19.94M 10-K · filed 2016-03-14 | -$276.56M 10-K · filed 2014-03-13 | ||||||||||
| 2013-09-30 | -$4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$8.84M derived: sum of 2 quarters · filed 2014-11-13 | -$15.60M 10-Q · filed 2014-11-13 | -$22.94M derived: sum of 4 quarters · filed 2015-03-25 | -$272.22M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | -$4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$11.46M 10-Q · filed 2014-08-14 | -$18.80M derived: sum of 3 quarters · filed 2015-03-25 | -$26.45M derived: sum of 4 quarters · filed 2015-03-25 | -$268.08M 10-Q · filed 2013-08-07 | ||||||||||
| 2013-03-31 | -$6.76M 10-Q · filed 2014-05-15 | -$14.10M derived: sum of 2 quarters · filed 2015-03-25 | -$21.75M derived: sum of 3 quarters · filed 2015-03-25 | -$29.70M derived: sum of 4 quarters · filed 2015-03-25 | -$263.38M 10-Q · filed 2013-05-08 | ||||||||||
| 2012-12-31 | -$7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | -$14.99M derived: sum of 2 quarters · filed 2015-03-25 | -$22.94M derived: sum of 3 quarters · filed 2015-03-25 | -$29.55M 10-K · filed 2015-03-25 | -$256.62M 10-K · filed 2013-03-18 | ||||||||||
| 2012-09-30 | -$7.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$15.60M derived: sum of 2 quarters · filed 2013-11-12 | -$22.21M 10-Q · filed 2013-11-12 | -$28.35M derived: sum of 4 quarters · filed 2014-03-13 | -$249.28M 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | -$7.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$14.55M 10-Q · filed 2013-08-07 | -$20.70M derived: sum of 3 quarters · filed 2014-03-13 | -$26.84M derived: sum of 4 quarters · filed 2014-03-13 | -$241.63M 10-Q · filed 2012-08-07 | ||||||||||
| 2012-03-31 | -$6.60M 10-Q · filed 2013-05-08 | -$12.75M derived: sum of 2 quarters · filed 2014-03-13 | -$18.89M derived: sum of 3 quarters · filed 2014-03-13 | -$24.68M derived: sum of 4 quarters · filed 2014-03-13 | -$233.68M 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | -$6.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$12.28M derived: sum of 2 quarters · filed 2014-03-13 | -$18.07M derived: sum of 3 quarters · filed 2014-03-13 | -$24.49M 10-K · filed 2014-03-13 | -$227.07M 10-K · filed 2012-03-15 | ||||||||||
| 2011-09-30 | -$6.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$11.93M derived: sum of 2 quarters · filed 2012-11-08 | -$18.35M 10-Q · filed 2012-11-08 | -$220.93M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | -$5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$12.21M 10-Q · filed 2012-08-07 | |||||||||||||
| 2011-03-31 | -$6.42M 10-Q · filed 2012-05-10 | ||||||||||||||
| 2010-12-31 | -$9.25M 10-K · filed 2013-03-18 | ||||||||||||||
| 2010-09-30 | -$12.41M 10-Q · filed 2011-11-08 | ||||||||||||||
| 2010-06-30 | -$15.09M 10-K · filed 2013-03-18 | ||||||||||||||
| 2009-06-30 | -$13.80M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |